Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liesbeth Jansen

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2014
Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the NetherlandsJanet R Vos, Natalia Teixeira, Dorina M van der Kolk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E Lamberts, Maximillian Koch, Johannes S de Jong, et al.
Cancer Research|November 24, 2016
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Johannes S de Jong, Jürgen Glatz, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2014
Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the NetherlandsJanet R Vos, Natalia Teixeira, Dorina M van der Kolk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E Lamberts, Maximillian Koch, Johannes S de Jong, et al.
Cancer Research|November 24, 2016
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Johannes S de Jong, Jürgen Glatz, et al.
Pageof 5